People: Conceptus Inc (CPTS.O)

Summary

Name	Age	Since	Current Position
Kathryn Tunstall	61	2000	Chairman of the Board
D. Keith Grossman	52	2011	President, Chief Executive Officer, Director
Gregory Lichtwardt		2013	Chief Financial Officer, Treasurer
Julie Brooks	66	2010	Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Lori Ciano	49	2012	Executive Vice President - Human Resources
David Chung		2012	Executive Vice President, Chief Commercial Officer
Feridun Ozdil	48	2011	Executive Vice President - Research and Development
Joseph Sharpe	53	2013	Executive Vice President - Operations
Peter Wilson	68	2002	Lead Independent Director
John Bishop	68	2009	Independent Director
Thomas Bonadio	62	2003	Independent Director
Paul LaViolette		2008	Independent Director
Robert Toni	71	2003	Independent Director
Cindy Klimstra			Senior Director, Investor Relations

» Insider Trading

Biographies

Name	Description
Kathryn Tunstall	Ms. Kathryn A. Tunstall is Chairman of the Board of Conceptus Inc., since January 2000. She has served as a member of the Company’s Board of Directors since July 1993 and served as the Company’s President and Chief Executive Officer from July 1993 to December 1999. Prior to joining the Company, from June 1990 until June 1993, Ms. Tunstall served as President of the Edwards Less Invasive Surgery Division of Baxter International, a division engaged in development, manufacturing and marketing of cardiovascular catheters. Prior to her appointment as Division President, Ms. Tunstall served as Vice President of Worldwide Sales and Marketing, having joined the company in November 1986. From 1974 to 1986, Ms. Tunstall held various positions in finance, operations and marketing in two divisions of American Hospital Supply Corporation, including that of Vice President of Marketing of McGaw Laboratories, a pharmaceutical and medical device company. Ms. Tunstall served as a Director and a Compensation Committee Chair of Caliper LifeSciences, a publicly-traded biotechnology company, from February 2004 until it was acquired by PerkinElmer Inc. in November 2011. Ms. Tunstall holds a B.A. degree in Economics from the University of California and has also completed graduate level studies in Business and Healthcare Administration.
D. Keith Grossman	Mr. D. Keith Grossman serves as the President, Chief Executive Officer, Director of Conceptus Inc., since December 8, 2011. From September 2007 to December 2011, Mr. Grossman served as a Managing Director at Texas Pacific Group ("TPG"), a private equity firm, where he initiated and led the medical device venture investing effort and also served as a Senior Advisor to the firm's buyout fund from January 2011 to December 2011. Prior to joining TPG, Mr. Grossman spent 23 years in a variety of industry operating roles, including as President and Chief Executive Officer of Thoratec Corporation, a medical device company, from 1996 to 2006. Prior to joining Thoratec Corporation, Mr. Grossman was a Division President of Pharmaceuticals, Inc., from 1992 to 1995, at which time it was sold. From 1988 to 1992, Mr. Grossman served as the Vice President of Sales and Marketing for the Calcitek division of Sulzermedica (formerly Intermedics, Inc.). Prior to 1988, Mr. Grossman held various sales and marketing management positions within the McGaw Laboratories Division of American Hospital Supply Corporation. Mr. Grossman serves on the board of directors of Thoratec Corporation and served on the boards of directors of Intuitive Surgical, Inc. from May 2004 to April 2010 and Kyphon, Inc. from April 2007 until it was acquired by Medronic, Inc. in November 2007, as well as numerous private company boards. Mr. Grossman received a BS in life sciences from The Ohio State University and an MBA from Pepperdine University.
Gregory Lichtwardt	Mr. Gregory E. Lichtwardt is Chief Financial Officer, Treasurer of Conceptus Inc. Mr. Lichtwardt joined Conceptus as Executive Vice President, Treasurer and Chief Financial Officer in November 2003 and was promoted to Executive Vice President, Operations, and Chief Financial Officer in April 2008. From 2000 to 2002, he was Executive Vice President, Finance, Chief Financial Officer and Corporate Secretary of Innoventry, Inc., a financial services company. From 1993 to 2000, Mr. Lichtwardt was Vice President, Finance, Chief Financial Officer and Treasurer of Ocular Sciences, Inc., a worldwide developer and marketer of soft contact lenses. Prior to his employment with Ocular Sciences, Mr. Lichtwardt, from 1989 to 1993, held senior management positions in various divisions of Allergan Inc. Mr. Lichtwardt currently serves on the board of directors of Biolase Technology, Inc., a public medical and dental laser products company, where he also participates on the Audit, Compensation and Quality Compliance Committees. In addition to these positions, Mr. Lichtwardt has held various financial positions at AST Research, Inc. and at divisions of American Hospital Supply Corporation. He earned a B.B.A. degree from the University of Michigan and an M.B.A. degree from Michigan State University.
Julie Brooks	Ms. Julie A. Brooks is Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary of Conceptus Inc., since February 2010. Ms. Brooks joined Conceptus as Vice President, General Counsel and Corporate Secretary in November 2009 and was promoted to Executive Vice President, General Counsel, Secretary and Chief Compliance Officer in February 2010. Prior to joining Conceptus, Ms. Brooks was Senior Vice President and General Counsel for Perlegen Sciences, Inc., a biotechnology company developing genetic-based diagnostic tests, from November 2007 to November 2009. Previously, Ms. Brooks served as General Counsel for several medical device and life sciences companies, including Free & Clear, Inc., a healthcare company providing tobacco cessation services for company benefits programs, from 2006 to 2007, Access Health, Inc. a healthcare services company providing utilization management, from 1996 to 1999 and Westmark International, Inc. a diagnostic ultrasound and patient monitoring systems company (formerly part of Squibb), from 1986 to 1992, and for eCommerce companies including GiftCetificates.com, Inc. from 2002 to 2006 and eCharge, Inc. from 2000 to 2001. She previously was a director and compensation committee chair of Endosonics, Inc., a public intravascular ultrasound company. Brooks earned a J.D. degree from Santa Clara University, a Masters of Law in Taxation from Georgetown University, and an M.B.A. degree from the University of Washington, where she also earned B.A. degrees in Comparative Literature and in English Literature.
Lori Ciano	Ms. Lori Ciano serves as Executive Vice President - Human Resources of Conceptus, Inc., effective March 2012. From November 2011 to March 2012, Ms. Ciano was principal of a consulting company, Ciano Associates, which provided executive coaching services for several technology companies. Previously, she was Senior Vice President, Human Resources for Affymetrix Inc., a gene chip company, from 2006 to June 2010. Prior to Affymetrix, from 2003 to 2006 she was Vice President, Human Resources at Novellus Systems, Inc., where she was Senior Director, Customer Satisfaction from 2000 to 2003. Ms. Ciano also worked for Varian Associates from 1980 to 2000 in various management positions. Ms. Ciano earned a Masters degree in Psychology from JFK University, an M.B.A. degree from Santa Clara University and a B.S. in Marketing from San Jose State University.
David Chung	Mr. David Chung is appointed as Executive Vice President, Chief Commercial Officer of Conceptus Inc., effective August 13, 2012. Previously Mr. Chung was the President and Chief Executive Officer of Mitralis Medical, an early-stage transcatheter mitral valve repair company since 2011. Prior to Mitralis Medical, he was at Edwards Lifesciences/Baxter Healthcare for 15 years where he held sales, marketing, and operations leadership positions with increasing scale and responsibility. From 2008 to 2011, Mr. Chung served as Global Vice President, Commercial Operations, Heart Valve Therapy, and from 2003 to 2008 as Vice President, Sales and Marketing, Heart Valve Therapy. From 1996 to 2003, Mr. Chung held a variety of sales, sales operations and marketing positions for Edwards. Prior to Edwards Lifesciences, Mr. Chung held sales positions at Pfizer-Schneider Interventional Cardiology from 1994 to 1996 and Pfizer-Pharmaceuticals Roerig Division from 1991 to 1994. Mr. Chung served as a PATRIOT Missile officer in the United States Army from 1988 to 1991 and received a B.S. degree in General Engineering and International Relations at the United States Military Academy at West Point.
Feridun Ozdil	Dr. Feridun Ozdil, Ph.D., serves as Executive Vice President - Research and Development of Conceptus Inc., since June 2011. Previously Dr. Ozdil was Senior Vice President of Research and Development at Nanovasc, Inc., a VC-backed private medical device start-up company, from April 2010 to June 2011. From July 2009 to Feb 2010, he was Senior Vice President of Research and Development and Manufacturing operations, and Chief Scientific Officer for Angioscore, Inc., a VC-backed, private medical device company, where he was Vice President of Research and Development and Chief Scientific Officer from October 2006 to July 2009. Previously, Dr. Ozdil held several management positions at Medtronic Cardiovascular from 1998 to 2006, with his most recent position as Senior Director of Research and Development, Science and Technology. Dr. Ozdil earned a B.S. in mechanical engineering from Bogazici University, Istanbul, Turkey and his M.S. and Ph.D in mechanical engineering from Florida Atlantic University.
Joseph Sharpe	Mr. Joseph Sharpe is appointed as the Executive Vice President - Operations of Conceptus, Inc. He has 25 years of experience in the medical device field. Before joining the Company, Mr. Sharpe came out of semi-retirement to serve as the Senior Vice President of Operations at Optovue, Inc., from September 2010 to January 2013. Before that, Mr. Sharpe served as Vice President of Operations at Thoratec Corporation from 1997 to 2006. Prior to his tenure at Thoratec Corporation, Mr. Sharpe held numerous positions in operations with Baxter Healthcare Corporation from 1983 to 1997, with increasing scale and responsibility culminating in his role as Director of Operations from 1992 to 1997. Mr. Sharpe received a B.S. degree in mechanical engineering from the University of Massachusetts at Lowell.
Peter Wilson	Mr. Peter L. Wilson is Lead Independent Director of Conceptus Inc., since November 2002. He has served as a member of the Company’s Board of Directors since December 2001. Mr. Wilson was President and Chief Executive Officer of Patient Education Systems from 1995 to 1998. Between 1992 and 1994, Mr. Wilson was an independent consultant in healthcare business development and marketing. From 1972 to 1992, Mr. Wilson worked for Proctor & Gamble / Richardson Vicks, where he held various positions including President of Richardson Vicks, Vice President/General Manager of Proctor & Gamble Vicks Healthcare, President/General Manager of the Vidal Sassoon Division and President/General Manager of the Personal Care Division. Mr. Wilson serves as Lead Independent Director for publicly-traded ArthroCare Corporation, a medical device company. Mr. Wilson holds a B.A. degree from Princeton University and an M.B.A. degree in Marketing from Columbia University.
John Bishop	Mr. John L. Bishop is Independent Director of Conceptus Inc., since February 2009. Mr. Bishop has served as Chief Executive Officer and a director of Cepheid, Inc., a molecular diagnostics company, since April 2002. Prior to this, he served as Chief Executive Officer of Vysis Inc., a genomic disease management company from 1996 to March 2002, as President and a Director from 1993 to March 2002 and as Director from 1993 to 2001. From 1991 until November 1993, Mr. Bishop was Chairman and Chief Executive Officer of MicroProbe Corporation, a biotechnology company, and, from 1987 until 1991, was Chairman and Chief Executive Officer of Source Scientific Systems, a biomedical instrument manufacturing company. He began his career at American Hospital Supply Company in 1968 and held various management positions of increasing responsibility both in the United States and overseas. Mr. Bishop holds a B.S. degree from the University of Miami.
Thomas Bonadio	Mr. Thomas F. Bonadio is Independent Director of Conceptus Inc., since September 2003. Mr. Bonadio is the founder and managing partner of The Bonadio Group, an independent provider of accounting, business advisory and financial services. He founded this business in 1978, following seven years with Arthur Andersen & Co. Mr. Bonadio serves as a Director and Audit Committee Chair of Torvec, Inc., a publicly-traded automotive engineering company. Mr. Bonadio is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants and the New York State Society of Certified Public Accountants. He holds a B.B.A. degree from St. John Fisher College, and is the past chairman of St. John Fisher College’s Board of Trustees.
Paul LaViolette	Mr. Paul A. LaViolette is Independent Director of Conceptus Inc., since December 2008. Mr. LaViolette is currently a Partner with SV Life Sciences Advisers, LLC. Mr. LaViolette most recently served as Chief Operating Officer of Boston Scientific Corporation until his retirement in June 2008. He joined Boston Scientific in January 1994 and had been Chief Operating Officer since 2004. During his 15-year career at Boston Scientific, Mr. LaViolette ran the International, Endosurgery, Interventional Cardiology and Cardiovascular businesses. Prior to joining Boston Scientific, he spent nine years with C.R. Bard, Inc. and four years with Kendall Company. Mr. LaViolette currently serves on the Board of Directors of Thoratec, Inc., a publicly-traded medical device company, and Trans1, Inc., a publicly-traded medical device company where he served as Lead Independent Director. He also serves as a director for privately-held DJO, Cameron Health, CardioKinetix, CSA Medical, Direct Flow Medical, Inc., DC Devices, Cardiofocus (Chairman), Transenterix (Chairman) and ValenTx, Inc. Mr. LaViolette holds a B.A. degree from Fairfield University and an M.B.A. degree from Boston College.
Robert Toni	Mr. Robert V. Toni is Independent Director of Conceptus Inc., since October 2003. Mr. Toni retired in October 2002 from Closure Medical Corporation, where he held the position of President and Chief Executive Officer and served on the Executive Committee for eight years. Prior to his role at Closure Medical, Mr. Toni was General Manager and Executive Vice President of Marketing and Sales for Iolab Corporation, a division of Johnson and Johnson for five years and held a number of senior positions with CooperVision Cilco, a division of Cooper Labs for seven years, including his last position as Division President. Mr. Toni’s earlier career primarily included financial management positions for several companies, including V.P. General Manager of Sonometric Division of Rorer Pharmaceuticals, Controller at Sterndent Corporation, AMF Thermatool and Department Head of Cost Accounting for the Chevrolet Division of General Motors, Tarrytown Plant. Mr. Toni holds a B.B.A. degree from Iona College.
Cindy Klimstra

Basic Compensation

Name	Fiscal Year Total
Kathryn Tunstall	181,072
D. Keith Grossman	5,182,780
Gregory Lichtwardt	642,049
Julie Brooks	608,891
Lori Ciano	--
David Chung	--
Feridun Ozdil	808,763
Joseph Sharpe	--
Peter Wilson	--
John Bishop	--
Thomas Bonadio	--
Paul LaViolette	--
Robert Toni	--
Cindy Klimstra	--

As Of 30 Dec 2011

Options Compensation

Name	Options	Value
Kathryn Tunstall	343,333	1,921,790
D. Keith Grossman	0	0
Gregory Lichtwardt	210,000	220,800
Julie Brooks	0	0
Lori Ciano	0	0
David Chung	0	0
Feridun Ozdil	0	0
Joseph Sharpe	0	0
Peter Wilson	0	0
John Bishop	0	0
Thomas Bonadio	0	0
Paul LaViolette	0	0
Robert Toni	0	0
Cindy Klimstra	0	0

Insider Trading

Name	Shares Traded	Price
TUNSTALL KATHRYN A	20,000	$14.35
BONADIO THOMAS F	12,500	$5.70
BONADIO THOMAS F	5,000	$26.00
BONADIO THOMAS F	12,500	$26.00
BONADIO THOMAS F	5,000	$10.19
WILSON PETER L	10,000	$14.20
WILSON PETER L	30,000	$14.20
WILSON PETER L	30,000	$25.00
YU EDWARD	458	$23.50
BROOKS JULIE A	366	$23.50
LICHTWARDT GREGORY E	366	$23.50
BONADIO THOMAS F	19,412	$13.51
BONADIO THOMAS F	19,412	$23.00
BONADIO THOMAS F	9,144	$23.00
BONADIO THOMAS F	9,144	$13.51
BONADIO THOMAS F	600	$13.51
BONADIO THOMAS F	600	$23.00
BROOKS JULIE A	1,146	$22.33
LICHTWARDT GREGORY E	1,146	$22.33
OZDIL FERIDUN	917	$22.33
YU EDWARD	458	$22.33
LICHTWARDT GREGORY E	641	$21.44
BONADIO THOMAS F	2,344	$23.00
BONADIO THOMAS F	2,344	$13.51
BONADIO THOMAS F	8,500	$13.51

» Full list on Insider Trading

People: Conceptus Inc (CPTS.O)

Related Topics:

Summary

Biographies

Basic Compensation

Options Compensation

Related Topics: